Jacobs Levy Equity Management, Inc Vir Biotechnology, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 350,265 shares of VIR stock, worth $3.03 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
350,265
Previous 316,792
10.57%
Holding current value
$3.03 Million
Previous $2.82 Million
6.95%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding VIR
# of Institutions
220Shares Held
87.6MCall Options Held
127KPut Options Held
1.19M-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$144 Million1.03% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$142 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$113 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$48.6 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.57MShares$30.9 Million0.63% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.15B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...